share_log

Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $93

Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $93

Needham維持對merit medical systems的買入評級,將價格目標上調至93美元。
Benzinga ·  07/02 01:45

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $85 to $93.

Needham分析師Mike Matson認爲,Merit Medical Systems(納斯達克股票代碼:MMSI)應該買入,並將目標價從85美元提高至93美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論